Validation of Biomarker-Based ABCD Score in Atrial Fibrillation Patients with a Non-Gender CHA < sub > 2 < /sub > DS < sub > 2 < /sub > -VASc Score 0-1: A Korean Multi-Center Cohort

CONCLUSION: The biomarker-based ABCD score demonstrated improved stroke risk stratification in AF patients with non-gender CHA2DS2-VASc score 0-1. Furthermore, NOAC with an ABCD score ≥1 was associated with significantly lower stroke rate in AF patients with non-gender CHA2DS2-VASc score 0-1.PMID:36168241 | DOI:10.3349/ymj.2022.0157
Source: Yonsei Medical Journal - Category: Universities & Medical Training Authors: Source Type: research